Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters










Database
Language
Publication year range
1.
J Med Chem ; 64(21): 15758-15771, 2021 11 11.
Article in English | MEDLINE | ID: mdl-34546755

ABSTRACT

Rose bengal is an anionic dye considered as a potential photosensitizer for anticancer photodynamic therapy. The clinical utility of rose bengal is hampered by its short half-life, limited transmembrane transport, aggregation, and self-quenching; consequently, efficient drug carriers that overcome these obstacles are urgently required. In this study, we performed multilevel in vitro and in silico characterization of interactions between rose bengal and cationic poly(amidoamine) (PAMAM) and poly(propyleneimine) (PPI) dendrimers of the third and fourth generation and assessed the ability of the resultant complexes to modulate the photosensitizing properties of the drug. We focused on explaining the molecular basis of this phenomenon and proved that the generation- and structure-dependent binding of the dye by the dendrimers increases the cellular uptake and production of singlet oxygen and intracellular reactive oxygen species, leading to an increase in phototoxicity. We conclude that the application of dendrimer carriers could enable the design of efficient photodynamic therapies based on rose bengal.


Subject(s)
Dendrimers/chemistry , Photochemotherapy , Photosensitizing Agents/pharmacology , Polypropylenes/chemistry , Rose Bengal/pharmacology , Carcinoma, Basal Cell/metabolism , Carcinoma, Basal Cell/pathology , Cell Line, Tumor , Drug Screening Assays, Antitumor , Humans , Molecular Structure , Photosensitizing Agents/metabolism , Reactive Oxygen Species/metabolism , Rose Bengal/metabolism , Skin Neoplasms/metabolism , Skin Neoplasms/pathology
SELECTION OF CITATIONS
SEARCH DETAIL
...